13.02.2013 Views

BOOKS OF RtfiDIfGS - PAHO/WHO

BOOKS OF RtfiDIfGS - PAHO/WHO

BOOKS OF RtfiDIfGS - PAHO/WHO

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

GREENLAND ET AL.<br />

3. Cornfleld J, Haenszel WH. Some aspects of retrospective<br />

studies. J Chron Dis 1960;11:523.<br />

4. Mantel N, Haenszel WH. Statistical aspects of<br />

the analysis of data from retrospective studies of disease.<br />

Natl Cancer lnst Monogr 1959;22:719.<br />

5. Neutra RR, Drolette ME. Estimating exposurespecific<br />

rates from case-control studies using Bayes'<br />

theorem. Am J Epidemiol 1978;108:214.<br />

6. Prentice RL, Pyke R. Logistie disease incidence<br />

models and case-control studies. Biometrika<br />

1979;66:403.<br />

7. Schlesselman JJ. Samnle size requirements in<br />

cohort and case-control studies of disease. Am J<br />

Epidemiol 1974;99:381.<br />

8. Dom HF. Some problems arising in prospective<br />

and retrospecti ve studies of the etiology of disease. N<br />

Engl J Med 1959;261:571.<br />

Appendix<br />

MEDIcL CARE<br />

9. Kleinbaum DG, Morgenstern H, Kupper LL.<br />

Selection bias in epidemiologic studies. Am J<br />

Epidemiol (in preas).<br />

10. Sackett DL. Bias in analytic research. J Chron<br />

Dis 1979;32:51.<br />

11. Cole P. The evolving case-control study. J<br />

Chron Dis 1979;32:15.<br />

12. Feinstein AR. Clinical biostatistics. St. Louis:<br />

Mosby, 1977.<br />

13. Greenland S, Neutra RR. Control of confound.<br />

ing in technology assessment. Int J Epidemiol (in<br />

press).<br />

14. Miettinen OS. Efficacy of therapeutic<br />

practice-will epidemiology provide the answers?<br />

In: Melmon KL, ed. Drug therapeutics. Elsevier:<br />

New York, 1980.<br />

The rates given in Tables 1 and 2 were computed from the casecontrol<br />

data using Bayes' theorem. A detailed and general discussion of<br />

this method is given in reference 5. Briefly, suppose we know the<br />

overall rate of the outcome, P(D), the probability of exposure among<br />

cases, P(E/D), and the probability of exposure among noncases, P(E I<br />

D). Letting P(D) = 1 - P(D), Bayes' theorem states that the outcome<br />

rate among exposed persons, P(D/E), is given by<br />

P(D 1 E) = P(E I D)P(D)<br />

P(E 1 D)P(D) + P(E D)PD)<br />

In our NICU study, the total size of the target population (unit A + unit<br />

B) was equal to the number of cases (61) plus twice the number of<br />

controls (2 x 150)or 361; the ital number ofcases over the study period<br />

was 61; and so P(D) = 61/361 = 0.169 and P(OD) = 0.831. To illustrate<br />

Bayes' theorem, consider computation of the rate in the first row of<br />

Table 1. Here the exposure is "unit A," P(E 1 D) = 43/61 = 0.705, and<br />

P(E [D) is estimated as 78/150 = 0.520. Thus, using Bayes' theorem<br />

P(D 1 E), the rate in unit A, is estimated as<br />

or 21.6 per cent.<br />

- 107 -<br />

P(D | E) = 0.705(0.169) = .216<br />

0.705 (0.169) + 0.520 (0.831)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!